Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather R Hill

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Infectious Diseases|May 6, 2014
Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adultsS Todd Callahan, Mark Wolff, Heather R Hill, et al.
Vaccine|August 31, 2015
Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccineJesse D Troy, Heather R Hill, Marian G Ewell, et al.
Transfusion|July 31, 2002
Alkaline CPD and the preservation of RBC 2,3-DPGJohn R Hess, Heather R Hill, Cynthia K Oliver, et al.
Transfusion|June 26, 2003
Twelve-week RBC storageJohn R Hess, Heather R Hill, Cindy K Oliver, et al.
The Journal of Infectious Diseases|February 5, 2015
Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years OldWendy A Keitel, Lisa A Jackson, Srilatha Edupuganti, et al.
Vaccine|May 14, 2013
Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenarioSharon E Frey, Patricia L Winokur, Robert A Salata, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Infectious Diseases|May 6, 2014
Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adultsS Todd Callahan, Mark Wolff, Heather R Hill, et al.
Vaccine|August 31, 2015
Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccineJesse D Troy, Heather R Hill, Marian G Ewell, et al.
Transfusion|July 31, 2002
Alkaline CPD and the preservation of RBC 2,3-DPGJohn R Hess, Heather R Hill, Cynthia K Oliver, et al.
Transfusion|June 26, 2003
Twelve-week RBC storageJohn R Hess, Heather R Hill, Cindy K Oliver, et al.
The Journal of Infectious Diseases|February 5, 2015
Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years OldWendy A Keitel, Lisa A Jackson, Srilatha Edupuganti, et al.
Vaccine|May 14, 2013
Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenarioSharon E Frey, Patricia L Winokur, Robert A Salata, et al.
Pageof 1